Tonix pharmaceuticals regains compliance with nasdaq minimum bid price requirement

Chatham, n.j., june 26, 2024 (globe newswire) -- tonix pharmaceuticals holding corp. (nasdaq: tnxp) (tonix or the company), a fully-integrated biopharmaceutical company, today announced that it has regained compliance with the minimum bid price requirement for continued listing on the nasdaq capital market. on june 26, 2024, tonix received a letter from the nasdaq stock market llc stating that because tonix's shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, tonix's stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the nasdaq capital market, as set forth in nasdaq listing rule 5550(a)(2), and the matter is now closed.
NDAQ Ratings Summary
NDAQ Quant Ranking